Replies to post #755962 on NorthWest Biotherapeutics Inc (NWBO)

[NotSure2]

Why is it that almost all of you never considered looking at the stats that Hoffman and others posted in late 2023 about MHRA aproval timelines from submission time to aproval? And then choose the longest and apply it to NWBO (not because of NWBO bad, but because it is a novel drug, trial old with lots of different locations, complicated/no precedent (as said in asm/10q in the past), and smaller team).

This will put us late 2025 to 1st quater 2026.

But no, lets go with: This person found statistics based on this and that, and this and that, therefore lets post that approval is coming with the next month or 2, then we just repeat over and over, find NEW STATS from this person that claim they did their homework....

Repeat again, attack anyone suggesting it might take longer.

Not many people interested after years of doing this....

NWBO? "Dude dont invest in that shit, its a bunch of people that sound like they know what they are talking about, pumping over and over non stop, and nothing ever happen. Be carefull not to fall in the trap."

[flipper44]

“One thing that bothers me immensely about the process is, that despite the fact the agency knows this technology inside and out, the agency supposedly highly prioritizes this cancer indication, supposedly prioritizes this amazing and unprecedented type of safety profile, know its potential (combos/versions), understand its impact on long term survival, have over a decade experience with the therapy in compassionate treatment, picked through and certified all relevant manufacturing, understand patient need, and despite all that, they’re incredibly slow.

Patients are waiting.”